By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

European Commission (EC) 

Rue Joseph II
Jozef II straat 70
Brussels    B-1000  Belgium
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
Helsinn Group Release: The European Commission (EC) Approves ALOXI (palonosetron HCl) Injection To Prevent Nausea And Vomiting Due To Chemotherapy In Children As Young As One Month 5/27/2015 6:44:54 AM
European Commission (EC) Approves Amgen (AMGN)'s Vectibix (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer 4/6/2015 6:34:05 AM
The Medicines Company (MDCO) Receives European Commission (EC) Approval For Three Hospital Acute Care Products: KENGREXAL (Cangrelor), ORBACTIV (Oritavancin) And RAPLIXA(Sealant Powder) 3/30/2015 12:41:14 PM
Regulus Therapeutics, Inc. (RGLS) Receives Orphan Medicinal Product Designation From The European Commission (EC) For RG-012, A Microrna Therapeutic In Development For The Treatment Of Alport Syndrome 3/25/2015 6:43:15 AM
European Commission (EC) Clears Actavis (ACT)' Pending Acquisition Of Allergan (AGN) 3/16/2015 9:25:20 AM
Celgene International Sárl (CELG) Release: REVLIMID (Lenalidomide) Approved By European Commission (EC) For The Treatment Of Adult Patients With Previously Untreated Multiple Myeloma Who Are Not Eligible For Transplant 2/23/2015 11:47:46 AM
Zimmer (ZMH) Provides Update On The European Commission (EC) Review Process Relating To The Pending Merger With Biomet Inc. 2/10/2015 8:01:10 AM
European Commission (EC) Grants Marketing Authorization For Cerdelga® (Eliglustat), Genzyme Corporation (GENZ)’s Oral Therapy For Gaucher Disease Type 1 1/22/2015 10:47:57 AM
Enanta Pharmaceuticals, Inc. Announces European Commission (EC) Grants Marketing Authorizations For AbbVie (ABBV)’s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets)... 1/16/2015 9:50:01 AM
European Commission (EC) Grants Marketing Authorizations For AbbVie (ABBV)'s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) For The Treatment Of Chronic Hepatitis C 1/16/2015 7:55:05 AM
12345678
//-->